BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27103546)

  • 1. Molecular Testing and the Pathologist's Role in Clinical Trials of Breast Cancer.
    Han HS; Magliocco AM
    Clin Breast Cancer; 2016 Jun; 16(3):166-79. PubMed ID: 27103546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pathology of breast cancer: what a pathologist needs to know.
    Allison KH
    Am J Clin Pathol; 2012 Dec; 138(6):770-80. PubMed ID: 23161709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and future approach to the pathologist's assessment for targeted therapy in breast cancer.
    Pakkiri P; Lakhani SR; Smart CE
    Pathology; 2009 Jan; 41(1):89-99. PubMed ID: 19089744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biomarker analysis from a pathologist's view. Founding the rationale for personalised treatment of lung cancer].
    Buettner R; Heydt C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1502-8. PubMed ID: 24170079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging role of the molecular diagnostics laboratory in breast cancer personalized medicine.
    De Abreu FB; Wells WA; Tsongalis GJ
    Am J Pathol; 2013 Oct; 183(4):1075-1083. PubMed ID: 23920325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular classification of breast cancer: what the pathologist needs to know.
    Rakha EA; Green AR
    Pathology; 2017 Feb; 49(2):111-119. PubMed ID: 28040199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The changing role of pathologists from morphologists to molecular pathologists in the era of precision medicine.
    Masood S
    Breast J; 2020 Jan; 26(1):27-34. PubMed ID: 31876097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Technical considerations for KRAS testing in colorectal cancer. The pathologist's point of view].
    Bibeau F; Frugier H; Denouel A; Sabourin JC; Boissiere-Michot F
    Bull Cancer; 2009 Dec; 96 Suppl():S15-22. PubMed ID: 20034866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology of breast cancer in the last half century.
    Solanki M; Visscher D
    Hum Pathol; 2020 Jan; 95():137-148. PubMed ID: 31682887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene-Expression-Based Predictors for Breast Cancer.
    Gupta A; Mutebi M; Bardia A
    Ann Surg Oncol; 2015 Oct; 22(11):3418-32. PubMed ID: 26215189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarker assessment and molecular testing for prognostication in breast cancer.
    Kos Z; Dabbs DJ
    Histopathology; 2016 Jan; 68(1):70-85. PubMed ID: 26768030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic Pathology and Biomarkers in Breast Cancer.
    Zhang Z; Tang P
    Crit Rev Oncog; 2017; 22(5-6):411-426. PubMed ID: 29604921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focusing on Preinvasive Neoplasia: A Molecular Frontier at the Pathologist's Fingertips.
    Borczuk AC
    Arch Pathol Lab Med; 2017 Dec; 141(12):1604-1605. PubMed ID: 29189065
    [No Abstract]   [Full Text] [Related]  

  • 14. Genomic profiling of breast cancers.
    Curtis C
    Curr Opin Obstet Gynecol; 2015 Feb; 27(1):34-9. PubMed ID: 25502431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Phenotype, Multigene Assays, and the Locoregional Management of Breast Cancer.
    Braunstein LZ; Taghian AG
    Semin Radiat Oncol; 2016 Jan; 26(1):9-16. PubMed ID: 26617205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung cancer biomarkers: present status and future developments.
    Cagle PT; Allen TC; Olsen RJ
    Arch Pathol Lab Med; 2013 Sep; 137(9):1191-8. PubMed ID: 23991729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive markers in breast cancer: An update on ER and HER2 testing and reporting.
    Calhoun BC; Collins LC
    Semin Diagn Pathol; 2015 Sep; 32(5):362-9. PubMed ID: 25770732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologists and liquid biopsies: to be or not to be?
    Hofman P; Popper HH
    Virchows Arch; 2016 Dec; 469(6):601-609. PubMed ID: 27553354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers in Breast Cancer: Where Are We and Where Are We Going?
    Duffy MJ; Walsh S; McDermott EW; Crown J
    Adv Clin Chem; 2015; 71():1-23. PubMed ID: 26411409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.